-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi Agrees To Buy Dynavax At $15.50 Per Share Valuing Company At $2.2B And Representing 39% Premium, Expanding Presence In Adult Immunization And Vaccine Development

Benzinga·12/24/2025 07:17:33
Listen to the news

Dynavax stockholders to receive $15.50 in cash, a 39% premium to Dynavax closing share price on December 23, 2025